Ligand-mediated active targeting for enhanced oral absorption

Drug Discovery Today

Volumn 19, Issue 7, 2014, Pages 898-904

  Zhang, Xingwang ^a,b   Wu, Wei ^a  

^a FUDAN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; LIGAND; TRANSFERRIN RECEPTOR; VITAMIN RECEPTOR; DRUG;

DENDRITIC CELL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; GOBLET CELL; HUMAN; INTESTINE CELL; INTESTINE EPITHELIUM; NONHUMAN; REVIEW; ANIMAL; BIOAVAILABILITY; DRUG EFFECTS; INTESTINE ABSORPTION; INTESTINE MUCOSA; METABOLISM; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; PROCEDURES;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; DRUG DELIVERY SYSTEMS; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; LIGANDS; PHARMACEUTICAL PREPARATIONS;

EID: 84903759477     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.03.001     Document Type: Review

References (60)

1. Y. Kawabata et al. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications Int. J. Pharm. 420 2011 1 10
2. L. Shen Functional morphology of the gastrointestinal tract Curr. Top. Microbiol. Immunol. 337 2009 1 35
3. M.C. Chen et al. A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery Biomaterials 32 2011 9826 9838
4. J. Weiss et al. Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters Biopharm. Drug Dispos. 31 2010 150 161
5. A. Bernkop-Schnürch Nanocarrier systems for oral drug delivery: do we really need them? Eur. J. Pharm. Sci. 49 2013 272 277
6. A. des Rieux et al. Targeted nanoparticles with novel non-peptidic ligands for oral delivery Adv. Drug Deliv. Rev. 65 2013 833 844
7. G. Russell-Jones Intestinal receptor targeting for peptide delivery: an expert's personal perspective on reasons for failure and new opportunities Ther. Deliv. 2 2011 1575 1593
8. B. Devriendt et al. Crossing the barrier: targeting epithelial receptors for enhanced oral vaccine delivery J. Control. Release 160 2012 431 439
9. Y. Kong et al. Near-infrared fluorescent ribonuclease-A-encapsulated gold nanoclusters: preparation, characterization, cancer targeting and imaging Nanoscale 5 2013 1009 1017
10. M. Moros et al. Monosaccharides versus PEG-functionalized NPs: influence in the cellular uptake ACS Nano 6 2012 1565 1577
11. W.Y. Yu et al. Saccharide modified pharmaceutical nanocarriers for targeted drug and gene delivery Curr. Pharm. Des. 15 2009 3826 3836
12. S.C. Diesner et al. Use of lectin-functionalized particles for oral immunotherapy Ther. Deliv. 3 2012 277 290
13. E.M. Pridgen et al. Transepithelial transport of Fc-targeted nanoparticles by the neonatal Fc receptor for oral delivery Sci. Transl. Med. 5 2013 213ra167
14. G.J. Russell-Jones The potential use of receptor-mediated endocytosis for oral drug delivery Adv. Drug Deliv. Rev. 46 2001 59 73
15. A.D. Vadlapudi et al. Targeted lipid based drug conjugates: a novel strategy for drug delivery Int. J. Pharm. 434 2012 315 324
16. A.K. Petrus et al. Traveling the vitamin B12 pathway: oral delivery of protein and peptide drugs Angew Chem. Int. Ed. 48 2009 1022 1028
17. K.B. Chalasani et al. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles J. Control. Release 122 2007 141 150 (Pubitemid 47361403)
18. C.H. Fazen et al. Oral delivery of the appetite suppressing peptide hPYY(3-36) through the vitamin B12 uptake pathway J. Med. Chem. 54 2011 8707 8711
19. J.H. Hamman et al. Targeting receptors, transporters and site of absorption to improve oral drug delivery Drug Target Insights 2 2007 71 81
20. X.B. Zhao et al. Targeted drug delivery via folate receptors Exp. Opin. Drug Deliv. 5 2008 309 319
21. J. Pacha Development of intestinal transport function in mammals Physiol. Rev. 80 2000 1633 1667
22. K.E. Anderson et al. Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form Pharm. Res. 18 2001 316 322 (Pubitemid 32595819)
23. S.S.N. Ling et al. Oral bioavailability enhancement of a hydrophilic drug delivered via folic acid-coupled liposomes in rats J. Pharm. Pharmacol. 61 2009 445 449
24. X. Zhang et al. Biotinylated liposomes as potential carriers for the oral delivery of insulin Nanomedicine 10 2014 167 176
25. H.H. Salman et al. Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles Vaccine 25 2007 8123 8132 (Pubitemid 350046324)
26. Z. Kokrashvili et al. Taste signaling elements expressed in gut enteroendocrine cells regulate nutrient-responsive secretion of gut hormones Am. J. Clin. Nutr. 90 2009 822s 825s
27. J. Zhang et al. Galactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages Biomaterials 34 2013 3667 3677
28. C.J. Lim, and W.C. Shen Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugs J. Control. Release 106 2005 273 286
29. L.M. Ensign et al. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers Adv. Drug Deliv. Rev. 64 2012 557 570
30. C.E. Bobst et al. Mass spectrometry study of a transferrin-based protein drug reveals the key role of protein aggregation for successful oral delivery Proc. Natl. Acad. Sci. U. S. A. 109 2012 13544 13548
31. Z.H. Zhang et al. Studies on lactoferrin nanoparticles of gambogic acid for oral delivery Drug Deliv. 20 2013 86 93
32. A.Q. Sun et al. Human organic solute transporter (hOST): protein interaction and membrane sorting process Int. J. Biochem. Mol. Biol. 3 2012 290 301
33. S.V. Gupta et al. Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach Mol. Pharm. 8 2011 2358 2367
34. V. Voigt et al. Transport of the areca nut alkaloid arecaidine by the human proton-coupled amino acid transporter 1 (hPAT1) J. Pharm. Pharmacol. 65 2013 582 590
35. D. Gupta et al. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue Mol. Pharm. 10 2013 512 522
36. Z.T. Yan et al. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics Mol. Pharm. 8 2011 319 329
37. S.H. Luo et al. Targeting SVCT for enhanced drug absorption: synthesis and in vitro evaluation of a novel vitamin C conjugated prodrug of saquinavir Int. J. Pharm. 414 2011 77 85
38. I. Tamai Oral drug delivery utilizing intestinal OATP transporters Adv. Drug Deliv. Rev. 64 2012 508 514
39. J. Kunisawa et al. Gut-associated lymphoid tissues for the development of oral vaccines Adv. Drug Deliv. Rev. 64 2012 523 530
40. S.K. Kang et al. Identification of a peptide sequence that improves transport of macromolecules across the intestinal mucosal barrier targeting goblet cells J. Biotech. 135 2008 210 216
41. U. Wrackmeyer et al. Intelectin: a novel lipid raft-associated protein in the enterocyte brush border Biochemistry 45 2006 9188 9197 (Pubitemid 44156382)
42. D.J. Brayden et al. Intestinal Peyer's patch M cells and oral vaccine targeting Drug Discov. Today 10 2005 1145 1157 (Pubitemid 41334666)
43. A. Azizi et al. Enhancing oral vaccine potency by targeting intestinal M cells PLoS Pathog. 6 2010 e1001147
44. N. Zhang et al. Investigation of lectin-modified insulin liposomes as carriers for oral administration Int. J. Pharm. 294 2005 247 259 (Pubitemid 40462339)
45. M.A. Clark et al. Targeting polymerised liposome vaccine carriers to intestinal M cells Vaccine 20 2001 208 217
46. M. Garinot et al. PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination J. Control. Release 120 2007 195 204 (Pubitemid 47061488)
47. V. Fievez et al. Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination Eur. J. Pharm. Biopharm. 73 2009 16 24
48. M.K. Yoo et al. Targeted delivery of chitosan nanoparticles to Peyer's patch using M cell-homing peptide selected by phage display technique Biomaterials 31 2010 7738 7747
49. Y. Jin et al. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport Biomaterials 33 2012 1573 1582
50. A. Pusztai et al. Lectins and also bacteria modify the glycosylation of gut surface receptors in the rat Glycoconj. J. 12 1995 22 35
51. G. Nikitas et al. Transcytosis of Listeria monocytogenes across the intestinal barrier upon specific targeting of goblet cell accessible E-cadherin J. Exp. Med. 208 2011 2263 2277
52. J.L. Owen et al. New generation of oral mucosal vaccines targeting dendritic cells Curr. Opin. Chem. Biol. 17 2013 918 924
53. T.J. Curiel et al. Peptides identified through phage display direct immunogenic antigen to dendritic cells J. Immunol. 172 2004 7425 7431 (Pubitemid 38747604)
54. M. Mohamadzadeh et al. Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge Proc. Natl. Acad. Sci. U. S. A. 106 2009 4331 4336
55. M. Kathania et al. Colonic immune stimulation by targeted oral vaccine PLoS One 8 2013 e55143
56. L. Ray et al. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3- gallate Biomaterials 34 2013 3064 3076
57. M.R. Aji Alex et al. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting Eur. J. Pharm. Sci. 42 2011 11 18
58. Y. Yin et al. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin J. Control. Release 116 2006 337 345 (Pubitemid 44827411)
59. A. Makhlof et al. In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery Eur. J. Pharm. Biopharm. 77 2011 216 224
60. S. Subramanya et al. Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production J. Virol. 84 2010 2490 2501